论文部分内容阅读
目的探讨稳定型心绞痛降脂治疗的临床治疗效果。方法本实验选取我院在2011年8月份到2011年12月份进行治疗的稳定型心绞痛患者70例为对象,把所有患者随机分为35例观察组(辛伐他汀联合常规治疗组)和35例对照组(常规治疗组),后进行统计和观察比较两组患者的临床治疗情况。结果在治疗后6个月后,两组患者治疗前后TIB均有显著变化,且观察组优于对照组,差异有统计学意义(P<0.05);观察组治疗前后在运动耐量、运动试验阳性率、至ST段下移1 mm时间、ST段下移值等各项指标均有显著变化,P<0.05,差异有统计学意义;对照组治疗前后上述各项指标无明显变化,P>0.05,差别无统计学意义。结论治疗稳定型心绞痛时辅以降脂类药物(如辛伐他汀)联合用药,可有效改善心肌缺血症状,而且能减少因运动引发的心肌缺血的发生率。
Objective To investigate the clinical effect of lipid-lowering treatment of stable angina pectoris. Methods 70 patients with stable angina pectoris who were treated in our hospital from August 2011 to December 2011 were selected and randomly divided into 35 observation groups (simvastatin combined with conventional treatment group) and 35 patients The control group (conventional treatment group), followed by statistical analysis and observation of the clinical treatment of two groups of patients. Results After 6 months, the TIB of both groups changed significantly before and after treatment, and the observation group was better than the control group (P <0.05). Before and after the treatment, the exercise tolerance and motor test were positive P <0.05, the difference was statistically significant; the control group before and after treatment of the above indicators did not change significantly, P> 0.05 , The difference was not statistically significant. Conclusions The combination of lipid-lowering drugs (such as simvastatin) in the treatment of stable angina pectoris can effectively improve the symptoms of myocardial ischemia, and can reduce the incidence of myocardial ischemia caused by exercise.